Recombinant human growth hormone in pediatric patients using the FAERS database: Safety profile and update for the period 2004 - 2024
{{output}}
Objective: To investigate safety signals associated with recombinant human growth hormone (rhGH) using the FDA Adverse Event Reporting System (FAERS) and make recommendations for its application. ... ...
